Insulin-like growth factor-1 (IGF-1) induces the activation/phosphorylation of Akt kinase and cAMP response element-binding protein (CREB) by activating different signaling pathways in PC12 cells by Zheng, Wen-Hua & Quirion, Rémi
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
BMC Neuroscience
Open Access Research article
Insulin-like growth factor-1 (IGF-1) induces the 
activation/phosphorylation of Akt kinase and cAMP response 
element-binding protein (CREB) by activating different signaling 
pathways in PC12 cells
Wen-Hua Zheng1,2 and Rémi Quirion*2
Address: 1Department of Pharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China and 2Douglas Hospital 
Research Center, Department of Psychiatry, McGill University, Montreal, Quebec, H4H 1R3, Canada
Email: Wen-Hua Zheng - whzheng123@gmail.com; Rémi Quirion* - quirem@douglas.mcgill.ca
* Corresponding author    
Abstract
Background: Insulin-like growth factor-1 (IGF-1) is a polypeptide growth factor with a variety of
functions in both neuronal and non-neuronal cells. IGF-1 plays anti-apoptotic and other functions
by activating multiple signaling pathways including Akt kinase, a serine/threonine kinase essential for
cell survival. The nuclear transcription factor cAMP response element-binding protein (CREB) may
also be involved although relationships between these two proteins in IGF-1 receptor signaling and
protection is not clear, especially in neuronal cells.
Results:  IGF-1, in a concentration- and time-dependent manner, induces the activation/
phosphorylation of Akt and CREB in PC12 cells by activating different signaling pathways. IGF-1
induced a sustained phosphorylation of Akt while only a transient one was seen for CREB. The
phosphorylation of Akt is mediated by the PI3 kinase pathway while that of CREB is dependent on
the activation of both MAPK kinase and p38 MAPK. Moreover, the stimulation of PKC attenuated
the phosphorylation of Akt induced by IGF-1 while enhancing that of CREB. Survival assays with
various kinase inhibitors suggested that the activation/phosphorylation of both Akt and CREB
contributes to IGF-1 mediated cell survival in PC12 cells.
Conclusion: These data suggest that IGF-1 induced the activation of Akt and CREB using distinct
pathways in PC12 cells.
Background
Insulin-like growth factor-1 (IGF-1) is a polypeptide
trophic factor playing important roles in the survival and
differentiation of both neuronal and non-neuronal cells
[1,2]. The biological actions of IGF-1 are mediated by a
heterotetrameric tyrosine kinase receptor, the IGF-1 recep-
tor, which is similar to the insulin receptor both in struc-
ture and functions [2,3]. Binding of IGF-1 to its receptor
causes receptor autophosphorylation and the activation
of intrinsic tyrosine kinase. Activated receptor kinase
phosphorylates various intracellular proteins like the
insulin receptor substrate-1 (IRS-1) and Shc [3-5], leading
to the activation of multiple signaling pathways including
the phosphatidylinositide 3 kinase (PI3K)/Akt pathways
and the mitogen-activated protein (MAP) kinase (also
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called extracellular signal-regulated kinase; ERK;
[2,3,6,7]).
Akt, a key target of the PI3 kinase, is a serine/threonine
kinase that plays critical roles in the modulation of cell
development, growth and survival [8-10]. Stimulation of
cells with IGF-1 induces the activation of PI3 kinase lead-
ing to increased levels of phosphatidylinositol [3,4]
diphosphate [PI [3,4] P2] and phosphatidylinositol [3-5]
triphosphate [PI [3-5] P3] in target cells [11,12]. This
event recruits Akt to the plasma membrane where it is
phosphorylated by PI [3-5] P3 dependent kinase, (PDK)-
1 and -2, respectively at residues Thr308 and Ser473
[13,14]. The phosphorylation of these residues activates
Akt kinase which can then phosphorylate its many sub-
strates including glycogen synthase kinase-3 (GSK-3) [15],
the Bcl-2 family member Bad [16], caspase-9 [17], nuclear
factor-κB (NFκB) [18,19] and the winged-helix family of
transcription factors, FOXO1, FOXO3a and FOXO4
[1,10,20-22], leading to cell survival and the inhibition of
apoptosis [1,8,10,23].
The Ca2+/cyclic AMP response element-binding protein
(CREB) is one of the common nuclear targets of tyrosine
kinase receptors playing important roles in many biologi-
cal functions including neuronal plasticity, full axonal
development, memory consolidation, and neuroprotec-
tion [24-30]. This transcriptional factor belongs to the
CREB/ATF family and binds to the specific sequence, 5'-
TGACGTCA-3' known as CRE [31]. Activation of this tran-
scription factor requires the phosphorylation of the Ser-
133 residue which increases its association with CREB-
binding protein [32]. Several kinases including cyclic
AMP-dependent protein kinase (PKA), protein kinase-C
(PKC), calcium/calmodulin-dependent protein kinases,
MAPK/p38 MAPK/MAPKAP kinase-2, ribosomal S6
kinase (RSK) family of kinases, the mitogen and stress-
activated protein kinases 1 (MSK1) and Akt have been
shown to be capable of phosphorylating this protein on
Ser-133 residue [28,33-38].
IGF-I stimulates the phosphorylation of CREB and regu-
lates the expression of a number of CRE-containing genes
including bcl-2 and c-fos in several cell types [32,39].
Interestingly, CREB is reported as a possible target of Akt
[30,37] suggesting that it may be a target of Akt in IGF-1
mediated survival. However, reports about Akt as a CREB
kinase in IGF-1 signalling is still rather controversial with
one report suggesting that the phosphorylation of CREB
induced by IGF-1 is independent on Akt [40]. Moreover,
the signalling of CREB and Akt is cell type-dependent and
effectors specific [41]. Therefore, it is deemed important
to clarify the role of Akt in the phosphorylation of CREB
induced by IGF-1. Accordingly, we characterized here the
signalling of IGF-1 stimulated activation of CREB com-
pared to that of the PI3K/Akt in PC12 cells. Our data show
that IGF-1 promotes the phosphorylation of Akt and
CREB in these cells. The activation of Akt is mainly medi-
ated by the PI3 kinase pathway, while that of CREB is pri-
marily dependent on the activation of MAPK and p38-
MAP kinases revealing the differential regulation of these
two proteins by IGF-1 receptor signalling. It also argues
against a key role for Akt as a CREB kinase in PC12 cells.
The survival study suggests that the activation of these two
proteins likely contributes to the survival effects of IGF-1
in PC12 cells, with the PI3K/Akt kinase pathway playing a
predominant role.
Results
IGF-1 stimulates the phosphorylation of Akt and CREB in 
PC12 cells
To investigate the effect of IGF-1 on the activation/phos-
phorylation of Akt and CREB in neuronal cells, PC12 cells
were treated with 1–100 nM IGF-1 and the phosphoryla-
tion of Akt and CREB evaluated as described in Methods.
Figure 1 shows that IGF-1 induced the sustained phospho-
rylation of Akt while a transient phosphorylation was seen
for CREB. In the case of CREB, one additional band with
a lower molecular weight was seen in the blot. This band
represents p-ATF which has 100% homologous consensus
phosphorylation sequence with CREB and cross react with
IGF-1 induced time- and concentration-dependent phosphor- ylation of Akt and CREB in PC12 cells Figure 1
IGF-1 induced time- and concentration-dependent 
phosphorylation of Akt and CREB in PC12 cells. PC12 
cells were treated with 10 nM IGF-1 for various times and 
then the phosphorylation of Akt and CREB were determined 
as described in Methods. A). Time-dependence and (B). 
Concentration-dependence. Blots represent prototypical 
examples of experiments replicated at least 3 times.BMC Neuroscience 2006, 7:51 http://www.biomedcentral.com/1471-2202/7/51
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the anti-pCREB antibody [30]. Treatment of PC12 cells
with 10 nM IGF-1 caused a 3–5 fold increase in the phos-
phorylation of Akt at Ser-473. The phosphorylation
reached the highest level at 2.5 min and remained
unchanged for over 40 min. The phosphorylation of
CREB at Ser-133 was increased 2–3 fold by 10 nM IGF-1.
The induction of CREB phosphorylation was evident at 5
min, peaked at about 10 min and decreased thereafter (Fig
1A). IGF-1 also concentration-dependently stimulated the
phosphorylation of Akt and CREB in PC12 cells. The effect
of IGF-1 on Akt was seen at concentration as low as 0.33
nM while about 3 nM was required to induce the phos-
phorylation of CREB (Fig 1B).
The phosphorylation of Akt by IGF-1 is mediated by PI3 
kinase while MAPK and p38 MAPK regulate IGF-1 induced 
phosphorylation of CREB
Having established that IGF-1 can induce the phosphor-
ylation of Akt and CREB, we studied next the signaling
pathways mediating the action of IGF-1. PC12 cells were
pretreated with various kinase inhibitors before adding
IGF-1. Figure 2 (lane 6 versus 1) demonstrates that 10 nM
IGF-1 causes a 3–6 fold increase in the phosphorylation of
Akt. Pre-treatment with the PI3 kinase inhibitor,
LY294002 (25 µM), blocked IGF-1 induced activation of
Akt while slightly enhancing the phosphorylation of
CREB (Fig 2A, lane 7 vs 6). In contrast, the MEK inhibitor
PD98059 (25 µM; Fig 2, lane 8 vs 6), the p70 S6 kinase
pathway inhibitor rapamycin (25 nM, Fig 2, lane 9 vs 6),
and the p38 MAPK kinase inhibitor PD169316 (10 µM,
Fig 2, lane 10 vs 6) failed to significantly alter IGF-1-
induced Akt phosphorylation while partially but signifi-
cantly attenuating that of CREB. Additional experiments
revealed that the inhibitory effect of LY294002 on IGF-1-
induced Akt phosphorylation was concentration-depend-
ent (Fig. 3A) with a maximal effect observed at 50 µM.
To extend these results further, wortmannin, another well
known PI3 kinase inhibitor, was investigated in our
model. Wortmannin (100 nM) had no effect on IGF-1
stimulated phosphorylation of CREB but most signifi-
cantly blocked that of Akt demonstrating further the dif-
ferential mechanisms used by IGF-1 to regulate their
phosphorylation (Figure 3B).
MAPK kinase and p38 MAP kinase inhibitors 
concentration-dependently inhibit IGF-1-induced 
phosphorylation of CREB
To investigate in detail the role of MAPK and p38 MAPK
kinases on the phosphorylation of CREB, well established
inhibitors of these two pathways were used. As shown in
Figure 4, the MAPK pathway inhibitor, PD98059, concen-
tration-dependently inhibited IGF-1 stimulated phospho-
rylation of CREB (Fig 4A) and MAP kinase (Fig 4B).
Similarly, Figure 5 shows that the phosphorylation of p38
MAPK and CREB is concentration-dependently inhibited
by a p38 MAPK specific inhibitor, PD169316.
PMA attenuates IGF-1-induced phosphorylation of Akt 
while increasing CREB phosphorylation
We have previously shown that the activation of PKC by
PMA attenuated the phosphorylation of Akt induced by
IGF-1 [42]. We explored here the effects of such a treat-
ment on Akt versus CREB phosphorylation induced by
IGF-1. Pretreatment with PMA attenuated the tyrosine
phosphorylation of IRS-1 as we reported in our previous
study [42], and Akt while enhancing the phosphorylation
of CREB (Fig 6).
Treatment with a tyrosine kinase inhibitor blocks IGF-1 
receptor signaling, including the phosphorylation of Akt 
and CREB
Having established that IGF-1 stimulated the phosphor-
ylation of Akt via a PI3 kinase pathway while that of CREB
was mediated by the MAPK and p38 MAP kinase path-
ways, we studied next the upstream events involved in
these effects. IGF-1 stimulated the tyrosine phosphoryla-
tion of IGF-1R (Fig 7A, lane 3 vs lane 1), IRS-1 (Fig 7B,
IGF-1 induced the phosphorylation of Akt in PC12 cells via  the PI3 kinase pathway while MAPK and p38 MAPK pathways  mediated the activation of CREB induced by IGF-1 Figure 2
IGF-1 induced the phosphorylation of Akt in PC12 
cells via the PI3 kinase pathway while MAPK and p38 
MAPK pathways mediated the activation of CREB 
induced by IGF-1. Following treatment with different 
kinase inhibitors for 40 min, PC12 cells were exposed to 10 
nM IGF-1 and the phosphorylation of Akt and CREB was 
determined by Western blots using anti-phospho- Akt/CREB 
antibodies. The PI3 kinase inhibitor LY294002 inhibited IGF-
1-induced phosphorylation of Akt in PC12 cells while a 
MAPK pathway inhibitor PD98059, a p38 MAPK inhibitor 
PD169316 and a p70S6 pathway inhibitor rapamycin, did not 
have any significant effect. In contrast, the phosphorylation of 
CREB induced by IGF-1 was partially blocked by inhibitors of 
both MEK (PD98059) and p38 MAP kinase (PD169316). 
Blots represent prototypical example of experiments repli-
cated at least 3 times.BMC Neuroscience 2006, 7:51 http://www.biomedcentral.com/1471-2202/7/51
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lane 3 vs lane 1) and its association with PI3 kinase (Fig
7A and 7B, lane 3 vs lane 1), as well as those of Akt and
CREB (Fig 7C lane 3 vs lane 1). Pretreatment with the tyro-
sine kinase inhibitor, herbimycin A, inhibited these
actions of IGF-1 (Fig. 7A, 7B and 7C, lane 4 vs lane 3).
Hence, the tyrosine phosphorylation of the IGF-1 receptor
is essential for the activation/phosphorylation of these
downstream signaling proteins.
Both Akt and CREB can contribute to the survival effects 
of IGF-1 in PC12 cells
Figure 8 shows that various kinase inhibitors for Akt,
MAPK and p38 MAPK significantly attenuated the survival
effects of IGF-1 with the PI3K/Akt kinase inhibitor being
the most effective. Hence, while the PI3K/Akt pathway
plays a major role in the protective effects of IGF-1, the
MAPK/CREB pathway is also significantly involved even if
to the lesser extent (Fig. 8).
Effects of other trophic factors and agents in the 
phosphorylation of CREB
To compare the effect of other factors and agents to that of
IGF-1 on the phosphorylation of CREB, PC12 cells were
treated with IGF-1, EGF, FGF, FBS, PMA and the calcium
ionophore A23187, and the phosphorylation of CREB.
Treatments with 4 nM EGF, 4 nM FGF, 10% FBS, 200 nM
PMA and 10 µM A23187 significantly stimulated the
phosphorylation of CREB that are comparable to the
effect of IGF-1 (Fig 9).
Discussion
The present study demonstrates that IGF-1 is able to time-
and concentration-dependently stimulates the activation
of both Akt and CREB in PC12 cells. The activation of Akt
by IGF-1 is mediated by the PI3 kinase pathway while
MAPK and p38 MAPK are involved in IGF-1 induced
The MEK kinase inhibitor PD98059 attenuated IGF-1- induced activation of MAPK kinase and CREB in PC12 cells Figure 4
The MEK kinase inhibitor PD98059 attenuated IGF-
1-induced activation of MAPK kinase and CREB in 
PC12 cells. PC12 cells pretreated with various concentra-
tions of the MAPK pathway inhibitor PD98059 were incu-
bated with 10 nM IGF-1 for 10 min. Cells were collected and 
the activation of MAPK and CREB were determined as 
described in Methods. PD98059 concentration-dependently 
blocked the activation of MAPK stimulated by IGF-1. This 
inhibitor also attenuated the phosphorylation of CREB in a 
similar manner. Blots represent prototypical example of 
experiments replicated at least 3 times.
PI3 kinase inhibitors blocked the activation of Akt by IGF-1  while has no effect on the phosphorylation of CREB Figure 3
PI3 kinase inhibitors blocked the activation of Akt by 
IGF-1 while has no effect on the phosphorylation of 
CREB. PC12 cells pretreated with different concentrations 
of LY294002 or 100 nM wortmannin were stimulated with 
10 nM IGF-1 and the phosphorylation of Akt and CREB was 
determined. (A) LY294002 blocked IGF-1-induced phosphor-
ylation of Akt in a concentration-dependent manner while 
slightly enhancing the activation of CREB in PC12 cells. (B) 
100 nM wortmannin significantly blocked the activation of 
Akt while having no effect on CREB phosphorylation. Blots 
represent prototypical example of experiments replicated at 
least 3 times.BMC Neuroscience 2006, 7:51 http://www.biomedcentral.com/1471-2202/7/51
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phosphorylation of CREB. Survival assay revealed that
these various pathways contribute to the survival effects of
IGF-1 in PC12 cells.
IGF-I is a polypeptide trophic factor capable of supporting
growth and of preventing death in neuronal and non-neu-
ronal cells. The biological functions of this growth factor
are mediated by IGF-I receptors. Recent studies have
shown that both IGF-1 and its receptors are expressed in
the CNS [1,21,43], and their respective expression is
upregulated in response to injuries [1,44]. It is also well
established that IGF-1 protects the brain from hypoxic
and ischemic injuries [45]. IGF-1 is also neuroprotective
in a broad range of cells including cultured primary hip-
pocampal neurons. These neuroprotective effects likely
involve multiple signaling pathways but in particular the
PI3K/Akt kinase and MAPK-CREB pathways [2,30,46,47].
Consistent with these findings, our results show here that
IGF-1 is able to stimulate the activation of both the PI3K/
Akt kinase and MAPK-CREB pathways in PC12 cells.
Although mechanisms underlying the phosphorylation of
CREB have been extensively studied, the role of a given
signaling pathway in mediating the effect of a trophic fac-
tor on CREB remains somewhat controversial. For exam-
ple, while Akt has been suggested to act as a 'CREB kinase',
data obtained here are not fully supportive of such an
hypothesis. Indeed while IGF-1 induced the sustained
phosphorylation of Akt, only a transient one was seen for
CREB. Moreover, inhibitors of PI3K/Akt blocked the acti-
vation/phopsphorylation of Akt with almost no effect on
the phosphorylation of CREB. In contrast, MAPK and p38
kinase inhibitors significantly diminished IGF-1-induced
phosphorylation of CREB while only having a small effect
on Akt. Indeed, the MAPK pathway inhibitor PD98059
and the p38 MAPK kinase inhibitor, PD169316, at con-
centrations fully inhibiting MAPK and p38 kinase respec-
tively, significantly abrogated the phosphorylation of
CREB while having no significant effect on the activation
of Akt. Moreover, the phosphorylation of CREB induced
by IGF-1 is not inhibited by Akt inhibitors at concentra-
tions that fully blocked the phosphorylation of GSK3β, a
target of Akt in the IGF-1 signaling pathway (data not
shown). Finally, PMA, an activator of PKC, attenuated
IGF-1-induced activation of Akt while enhancing the
phosphorylation of CREB. Taken together, these data
reveal that IGF-1-induced phosphorylation of Akt and
CREB is mediated via distinct pathways and suggest that
PMA attenuated the phosphorylation of IGF-1-induced acti- vation of Akt while enhancing the phosphorylation of CREB Figure 6
PMA attenuated the phosphorylation of IGF-1-
induced activation of Akt while enhancing the phos-
phorylation of CREB. PC12 cells were treated with 400 
nM PMA before incubation with 10 nM IGF-1 and the phos-
phorylation of Akt and CREB determined. PMA treatment 
decreased the phosphorylation of Akt while increasing the 
activation of CREB. Blots represent prototypical example of 
experiments replicated at least 3 times.
The p38 MAP kinase is involved in the phosphorylation of  CREB induced by IGF-1 in PC12 cells Figure 5
The p38 MAP kinase is involved in the phosphoryla-
tion of CREB induced by IGF-1 in PC12 cells. PC12 
cells were treated with the p38 MAPK inhibitor PD169316 
(2.5–20 µM) and 10 nM IGF-1, and the phosphorylation of 
CREB and p38 MAPK were measured by Western blot with 
anti-phospho-CREB and phospho-p38MARK antibodies. PD 
169316 significantly blocked the phosphorylation of p38 
MAPK and CREB induced by IGF-1. Blots represent proto-
typical example of experiments replicated at least 3 times.BMC Neuroscience 2006, 7:51 http://www.biomedcentral.com/1471-2202/7/51
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CREB is not a direct substrate of Akt in IGF-1 receptor sig-
naling in PC12 cells.
In fact, MAPK and p38 MAPK most likely contribute to the
phosphorylation of CREB stimulated by IGF-1 in PC12
cells. However, the existence of kinase(s) which can actu-
ally phosphorylate CREB at Ser-133 has not been reported
in PC12 cells. MAPK and p38 MAPK cannot directly phos-
phorylate CREB at this residue as it is not a proline-
directed phosphorylation site [41]. Downstream targets of
these two kinases that may be able to phosphorylate CREB
in PC12 cells include the ribosomal S6 kinase (RSK) fam-
ily of kinases, MAPKAP kinase 2/3 and MSK1/2. For exam-
ple, the over-expression of inhibitory RSK2 mutants
reduced EGF-induced CREB phosphorylation [36] while
cells deficient for this kinase were found to be resistant to
EGF-stimulated CREB phosphorylation [48]. However,
Rsk-2-deficient cell lines have shown that this kinase is
not essential for the activation of CREB in response to
PDGF and IGF-1 [49].
MAPKAP kinase-2, an enzyme immediately downstream
of p38 MAP kinase, is able to phosphorylate CREB at
Ser133 in vitro, and has been suggested to play an impor-
tant role in FGF- or stress-induced phosphorylation of
CREB and ATF-1 in SK-N-MC cells [34]. However, a sub-
sequent report using PC12, HeLa and SK-N-MC cell lines
Multiple signaling pathways are involved in the survival effect  of IGF-1 in PC12 cells Figure 8
Multiple signaling pathways are involved in the sur-
vival effect of IGF-1 in PC12 cells. Following treatment 
with different kinase inhibitors for 40 min, PC12 cells were 
exposed to 10 nM IGF-1 for 24 hours and cell viability was 
determined by MTT as described in Methods. Cell survival of 
PC12 cells induced by IGF-1 is partially inhibited by various 
blockers, the PI3K inhibitor being the most effective. Data 
represent assays from at least three independent experi-
ments.
The tyrosine kinase inhibitor herbimycin A blocked IGF-1  signalling, including Akt and CREB activation, in PC12 cells Figure 7
The tyrosine kinase inhibitor herbimycin A blocked 
IGF-1 signalling, including Akt and CREB activation, 
in PC12 cells. PC12 cells pretreated with or without her-
bimycin A were stimulated with 10 nM IGF-1 and the tyro-
sine phosphorylation of IGF-1 R (A) and IRS-1 (B), their 
association with PI3K, as well as the phosphorylation of Akt 
and CREB (C) were determined. IGF-1 stimulated the tyro-
sine phosphorylation of these markers. Pretreatment of 
PC12 cells with herbimycin A blocked these events. Blots 
represent prototypical example of experiments replicated at 
least 3 times.BMC Neuroscience 2006, 7:51 http://www.biomedcentral.com/1471-2202/7/51
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failed to demonstrate a role for both RSK2 and MAPKAP-
2/3 as CREB kinases in signalling induced by TNF, NGF
and FGF [50]. The potential role of this kinase in IGF-1
induced CREB phosphorylation in PC12 cells hence
remains to be fully established.
MSK1 is a downstream kinase of the MAPK and p38
MAPK kinase pathways and is important in stress and
mitogen-induced CREB phosphorylation in fibroblasts,
PC12 cells and embryonic stem cells [38,50-52]. Since
both MAPK and p38 MAPK are involved in IGF-1 induced
phosphorylation of CREB in PC12 cells, MSK1 is thus a
possible intermediate step. Consistent with this hypothe-
sis, preliminary data have shown that blockade of MSK1
significantly inhibited IGF-1 stimulated phosphorylation
of CREB in PC12 cells (Zheng and Quirion, unpublished
results).
The biological significance of the finding that distinct
pathways are involved in IGF-1 induced phosphorylation
of Akt and CREB is not clear. Both proteins are known to
play central roles in cell survival [9,46,47,53]. The role of
Akt in cell survival was proposed first by Dudek and col-
leagues (1997) in a study showing that IGF-1-induced sur-
vival of cultured cerebellar granule cells was mediated by
this kinase [9]. Subsequently, Akt was shown to be a key
survival promoting kinase for a broad of range of factors
in a variety of cell type [1,22,46,47]. It is known that acti-
vated Akt can phosphorylate and hence inactivate proap-
optotic proteins such as the Bcl-2 family member Bad
[16], caspase-9 [17], GSK3 [15], FOXO transcription fac-
tors [21,22,47] and ASK1 [54]. Akt can also affect the
expression of Bcl-2 family members in target cells as well
as the function of NF-kappaB and CREB [46,47].
The MAPK-CREB pathway was also reported to play a
major role in neuronal survival including in PC12 cells
[47,53]. For example, MAPK can activate RSKs and MSK1/
2 [51,53]. RSKs are then able to phosphorylate the pro-
apoptotic protein Bad at Ser- 112suppressing Bad-medi-
ated apoptosis [53]. RSKs and possibly MSK1/2 are also
able to facilitate the phosphorylation of CREB at Ser-133,
leading to cell survival. Accordingly, the Akt and MAPK-
CREB pathways likely have additive effects in contributing
to the survival effects induced by IGF-1 in PC12 cells. This
is also exemplified by the action of Akt and MAPK in the
phosphorylation of Bad. In the presence of growth factors,
Akt is activated and phosphorylates Bad at Ser-136, inhib-
iting its pro-apoptotic effect [16]. In parallel, the activa-
tion of MAPK leads to the phosphorylation of Ser-112
further inhibiting Bad [53]. Hence, IGF-1 by acting via the
IGF-1 receptor complex and parallel downstream effectors
can inhibit various pro-apoptotic signals in a variety of
cells including PC12 cells.
Conclusion
In conclusion, this study shows that IGF-1-induced phos-
phorylation of Akt kinase is mediated by the PI3 kinase
pathway while that of CREB is regulated mainly by activat-
ing the MAPK and p38 MAPK pathways.
Methods
Materials
Human recombinant IGF-1 was obtained as a gift from
Genentech Inc (San Francisco, CA). LY294002, PD98059,
herbimycin A, rapamycin, PD169316, Akt inhibitors I and
II were purchased from Calbiochem (Bad Soden, Ger-
many) whereas wortmannin, leupeptin, aprotinin,
sodium vanadate and phorbol 12-myristate 13-acetate
(PMA) were from Sigma Chemical (St Louis, MO). U0126
was purchased from Promega (Madison, WI). Anti-phos-
pho-CREB-133, anti-CREB, anti-phospho-p38 MAPK,
anti-phospho-Akt, anti-phopho-GSK3β (Ser-9) and anti-
phospho-MAPK antibodies were obtained from Cell Sign-
aling Technology (Beverly, MA). Anti-Akt, anti-MAPK,
anti-p38 MAPK and all secondary antibodies conjugated
with horseradish peroxidase (HRP) were from Santa Cruz
Biotechnology (Santa Cruz, CA). Cell culture reagents
were purchased from GIBCO Life Technologies (Grand
EGF, FGF, FBS, PMA and the calcium ionophore-A23187  stimulated CREB phosphorylation in PC12 cells Figure 9
EGF, FGF, FBS, PMA and the calcium ionophore-
A23187 stimulated CREB phosphorylation in PC12 
cells. PC12 cells were treated with 10 nM IGF-1, 4 nM EGF, 
4 nM FGF, 10% FBS, 200 nM PMA and 10 µM A23187 and 
the phosphorylation of CREB was determined as described in 
Methods. All these agents stimulated CREB phosphorylation 
in PC12 cells. Blots represent prototypical examples of 
experiments replicated at least 3 times.BMC Neuroscience 2006, 7:51 http://www.biomedcentral.com/1471-2202/7/51
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Island, NY) whereas all other reagents were from Sigma
Chemical or Fisher Scientific (Nepean, ON).
Cell culture
PC12 cells were kindly provided by Dr. Gordon Guroff at
NICHD, NIH (Betheda, MD) and cultured as described
before. In brief, PC12 cells were maintained in 75 cm2
flasks in high glucose Dulbecco's Modified Eagle's
Medium (DMEM) supplemented with 5% (vol/vol) fetal
bovine serum (FBS), 5% horse serum, 100 µg streptomy-
cin/ml and 100 U penicillin/ml. Cells were incubated at
37°C with 5% CO2 humidified atmosphere. Stock culture
was routinely sub-cultured at 1:5 ratio at a week interval.
Treatments
Before each experiment, cells were detached using 5 mM
EDTA in Hank's balance buffer (HBS) and seeded in 12 or
6 well plates (coated with poly-D-lysine, 10 µg/ml) at a
density of 3–6 × 105cells/well in 2% serum medium for 24
hrs. Culture medium was replaced with DMEM 2 hr
before the desired reagents were added. To study the effect
of IGF-1 on the phosphorylation of Akt, CREB, MAPK,
p38 MAPK and GSK3beta, cells were treated with 10 nM
IGF-1 for 10 min. Alternatively, cells were pretreated with
wortmannin (0–2 µM, 30 min), LY294002 (6–50 µM, 30
min), rapamycin (50 nM, 30 min), PD98059 (6–50 µM,
40 min) or PD169316 (2.5–20 µM, 40 min) followed by
a stimulation with 10 nM IGF-1. For the experiments with
PKC, 400 nM PMA was added to cells 2.5 min prior to
IGF-1 stimulation.
Western blotting
Western blotting was performed as described earlier with
some modifications [1,23]. Briefly, treated cells from dif-
ferent experimental conditions were rinsed twice with ice
cold HBSS and lysed in either sample buffer [62.5 mM
Tris-HCl, pH 6.8, 2% w/v sodium dodecyl sulfate (SDS),
10% glycerol, 50 mM dithiothreitol (DTT) and 0.1% w/v
bromphenol blue] or RIPA buffer [50 mM Tris-HCl, pH
8.0, 150 mM NaCl, 1 mM EDTA, 1% Igepal CA-630, 0.1%
SDS, 50 mM NaF, 1 mM NaVO3, 5 mM phenyl-methyl-
sulfonyl fluoride, 10 µg/ml leupeptin, 10 µg/ml apro-
tinin]. Samples with equal amounts of protein were then
separated by 4–20% polyacrylamide gel electrophoresis
(PAGE), and the resolved proteins were electrotransferred
to Hybond-C Nitrocellulose. Membranes were incubated
with 5% non-fat milk in TBST (10 mM Tris-HCl, pH 8.0,
150 mM NaCl and 0.2% Tween-20) for 1 hr at room tem-
perature and incubated with appropriate primary anti-
body at 4°C overnight. Membranes were then washed
twice with TBST and probed with corresponding second
antibodies conjugated with HRP (anti/rat/mouse/rabbit/
goat-HRP) at room temperature for 1 hr. Membranes were
finally washed several times with TBST to remove
unbound secondary antibodies and visualized using an
ECL detection kit (Amersham Co, Toronto, ON). A part of
the SDS gel was stained with Coomassie Blue to ensure
the use of equal amounts of protein.
The respective phosphorylation of Akt, MAPK, CREB,
GSK3β (Ser-9) and p38 MAPK was determined by Western
blot using anti-phospho-Akt, anti-phospho-MAPK, anti-
phospho-CREB, anti-phopho-GSK3β (Ser-9) and anti-
phospho-p38 MAPK antibodies, respectively. Blots were
stripped and reprobed with anti-Akt, anti-MAPK, CREB,
GSK3β and p38 MAPK antibodies to ensure that equal
amounts of various proteins were present. The effect of
IGF-1 was determined by comparing the phosphorylation
of above protein and their unphosphorylated counterpart
or beta-actin levels in cell extracts determined as men-
tioned above.
Determination of tyrosine phosphorylation of the IGF-1 
receptor, IRS-1 and their interactions with PI3 kinase was 
established by immunoprecipitation
PC12 cells were treated with 10 nM IGF-1 for 8 min and
rinsed with cold phosphate buffer saline (PBS). After cen-
trifugation at 1000 g for 5 min at 4°C, cell pellets were
lysed on ice in pre-cold RIPA buffer for 20 min. Cell
lysates were then pelleted at 13,000 g for 10 min and the
concentration of protein in each sample was determined
using the Bio-Red dye-binding method with bovine serum
albumin (BSA) as standard. The supernatant with equal
amount of protein was incubated overnight at 4°C with
either anti-IGF-1R, anti-IRS-1 or anti-PI3 kinase antibod-
ies. Formed immunocomplexes were isolated by protein
A/G PLUS-agarose (Santa Cruz Biotechnology, Inc.), sep-
arated by 4–20% SDS gel and then tyrosine phosphoryla-
tion was determined by Western blot with a mixture of
anti-phosphotyrosine antibodies 4G10 and PY99. Blots
were striped and reprobed with PI3 kinase or IRS-1 anti-
bodies to evaluate the interaction of IGF-1R and IRS-1
with PI3 kinase. Finally, the blots were reprobed with
anti-IGF-1R, anti-IRS-1 or anti-PI3 kinase to ensure the
presence of equal amount of proteins.
Cell viability using the MTT assay
PC12 cells (10000 to 20000 cells/well) in serum -free
medium DMEM or DMEM supplemented with 1 % FBS
were added to 96- well plates and incubated at 37°C with
5% CO2 for 1 h. Cells were pretreated with 25 µM
LY294002, 25 µM PD98059, 10 µM PD169316 for 40
min and then 1 % FBS and 10 nM IGF-1 for 24–48 hours.
Following replacement of the medium with 0.5 mg/ml
MTT in DMEM, cells were returned into the incubator for
a 3-hr period. Cells and MTT formazan crystals were then
solubilized by trituration in a solution of isopropanol/
HCL (0.1 N) and the survival profile of these cells were
quantified by spectrophotometrically measuring the plateBMC Neuroscience 2006, 7:51 http://www.biomedcentral.com/1471-2202/7/51
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at 570 nM. Assays were repeated at least three to six times,
each in quadruplicate.
Statistical analysis
Data are expressed as mean ± SEM. A one-way ANOVA
with Newman-Keul test was used to establish statistical
significance set at p < 0.05.
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